Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes Mellitus
- 作者: Kornyushin O.1, Sonin D.1, Toropova Y.1, Pochkaeva E.1, Semikova G.2, Berko O.2, Zelinskaya I.1, Todosenko N.3, Litvinova L.3, Neimark A.4, Babenko A.4, Dergach K.5, Schpakov A.5, Galagudza M.1,2
-
隶属关系:
- Institute of Experimental Medicine
- I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
- Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University
- Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation
- Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences
- 期: 卷 168, 编号 2 (2019)
- 页面: 210-213
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/242365
- DOI: https://doi.org/10.1007/s10517-019-04676-w
- ID: 242365
如何引用文章
详细
The effects of bariatric surgeries (sleeve gastrectomy and ileal transposition) on the dynamics of changes in ghrelin level were studied in rats with severe decompensated type 2 diabetes mellitus under conditions of glucose challenge as well as on the size of myocardial infarction in these animals. Diabetes was modelled by high fat diet and a single administration of streptozotocin (25 mg/kg, intraperitoneally). Both bariatric surgeries significantly decreased glucose-induced ghrelin level in the blood of rats with type 2 diabetes mellitus, which attested to an increase in the tissue sensitivity to ghrelin. Sleeve gastrectomy resulted in a decrease in the size of myocardial infarction in diabetic rats, which was calculated as the ratio of the necrosis zone to the zone of the risk of myocardial infarction. Ileal transposition had no effect on this parameter. Our data can be used as the basis for optimization of treatment approaches when using bariatric surgery in the treatment of patients with severe forms of type 2 diabetes mellitus with a high risk of cardiovascular diseases.
作者简介
O. Kornyushin
Institute of Experimental Medicine
编辑信件的主要联系方式.
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
D. Sonin
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
Ya. Toropova
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
E. Pochkaeva
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
G. Semikova
I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
O. Berko
I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
I. Zelinskaya
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
N. Todosenko
Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University
Email: o.kornyushin@gmail.com
俄罗斯联邦, Kaliningrad
L. Litvinova
Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University
Email: o.kornyushin@gmail.com
俄罗斯联邦, Kaliningrad
A. Neimark
Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
A. Babenko
Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
K. Dergach
Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
A. Schpakov
Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg
M. Galagudza
Institute of Experimental Medicine; I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
俄罗斯联邦, St. Petersburg; St. Petersburg